flow trial semaglutide nejm Oral and Cardiovascular Outcomes in Patients with Type 2 Diabetes In the SURMOUNT-5 phase 3b

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management, with select agents subsequently approved for chronic weight management

For those who prefer no needles , oral GLP-1 options are now FDA-approved

Hyperpigmentation: This may be observed when the product is injected into areas with cellulite or stretch marks

Recommended use Take 13 capsules daily with a meal

My face is still my face but many years younger looking and absolutely natural

And when I went back to the GP who prescribed me, they told me the research they had until the point they had prescribed me, which was just a few weeks before, said my bowel wouldnt be affected, but now they know better. Research shows it slows down the bowel, so Im very concerned about doctors pushing a drug on patients that dont need it, says Dr Eva